A 22-year-old man with severe osteoporosis due to prolactinoma

Journal of Clinical Rheumatology

Volumn 19, Issue 6, 2013, Pages 341-343

  Dandinoǧlu, Taner ^a   Akarsu, Selim ^a   Tekin, Levent ^a   Arbal, Serkan ^a   Dinçer, Ümit ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CABERGOLINE; COLECALCIFEROL; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; PARATHYROID HORMONE[1-34]; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; BACKACHE; BONE DENSITY; CASE REPORT; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINOLOGIST; ERECTILE DYSFUNCTION; FATIGUE; FEMUR NECK; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; FRAGILITY FRACTURE; GONAD FUNCTION; HIP FRACTURE; HIP PAIN; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPROLACTINEMIA; HYPOPHYSIS; LIBIDO DISORDER; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RANGE OF MOTION; TABLET; TESTOSTERONE BLOOD LEVEL; VERTEBRA;

BONE DENSITY CONSERVATION AGENTS; DISEASE MANAGEMENT; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; SEVERITY OF ILLNESS INDEX; TERIPARATIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883655987     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31829ce57c     Document Type: Article

References (15)

1. Bolyakov A, Paduch DA Prolactin in men's health and disease. Curr Opin Urol. 2011; 21: 527-534.
2. Mazziotti G, Porcelli T, Mormando M., et al Vertebral fractures in males with prolactinoma. Endocr. 2011; 39: 288-293.
3. Fernandez A, Karavitaki N, Wass JA Prevalence of pituitary adenomas. Clin Endocrinol (Oxf). 2010; 72: 377-382.
4. Ben-Jonathan N., Mershon JL, Allen D.L., et al Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocrine Rev. 1996; 17: 639-669. (Pubitemid 26425260)
5. Morales T. Recent findings on neuroprotection against excitotoxicity in the hippocampus of female rats. J Neuroendocrinol. 2011; 23: 994-1001.
6. Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1989; 110: 526-531. (Pubitemid 19097320)
7. Taylor SD, Kelly TM Prolactinoma in a middle-aged man with an osteoporotic fracture. West J Med. 1989; 151: 80-82. (Pubitemid 19188310)
8. Gillam MP, Molitch ME, Lombardi G, et al Advances in the treatment of prolactinomas. Endocr Rev. 2006; 27: 485-534. (Pubitemid 44213229)
9. Klibanski A. Clinical practice. Prolactinomas. N Engl J Med. 2010; 362: 1219-1226.
10. Bilezikian JP. Osteoporosis in men. J Clin Endocrinol Metab. 1999; 84: 3431-3434. (Pubitemid 30645187)
11. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a worldwide projection. Osteoporos Int. 1992; 2: 285-289.
12. Mazziotti G, Mancini T, Mormando M., et al High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary. 2011; 14: 299-306.
13. Dos Santos Silva CM, Barbosa FR, Lima G.A., et al. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity (Silver Spring). 2011; 19: 800-805.
14. Greenspan SL, Neer RM, Ridgway E.C., et al Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1986; 104: 777-782. (Pubitemid 16115040)
15. Vilar L, Freitas MC, Naves L.A., et al Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest. 2008; 31: 436-444. (Pubitemid 352005743)